For research use only
| Cat No. | ABC-TC622S |
| Product Type | Human tumor cell line |
| Species | Human, Homo Sapiens |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Hemo-lymphocytic |
| Disease | Pleural effusion formation |
| Product Code | KMS-11/BTZ, KMS-11 Bortezomib Resistant Cells, KMS11/BTZ Myeloma Cells, BTZ-resistant KMS-11, Human Multiple Myeloma KMS-11 BTZ |
The KMS-11/BTZ cell line is a variant of the KMS-11 myeloma cell line, specifically developed to study resistance to bortezomib (BTZ).
The KMS-11/BTZ cell line is a variant of the KMS-11 myeloma cell line, specifically developed to study resistance to bortezomib (BTZ), a proteasome inhibitor used in multiple myeloma treatment. This cell line also retain the characteristics of KMS-11.
| Product Code | KMS-11/BTZ, KMS-11 Bortezomib Resistant Cells, KMS11/BTZ Myeloma Cells, BTZ-resistant KMS-11, Human Multiple Myeloma KMS-11 BTZ |
| Species | Human, Homo Sapiens |
| Cat.No | ABC-TC622S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Hemo-lymphocytic |
| Disease | Pleural effusion formation |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human tumor cell line |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
